Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT07548814
Active, not recruiting Observational

Evaluation of the 2-year AVF Utilization Rate

NCT07548814 · tracked via the Priya Life Science France tracker
Sponsor
University Paul Sabatier of Toulouse
Phase
Observational
Started
2018-01-01
Last updated
2026-04-23

Condition(s) studied

Dialysis Access DysfunctionFistulae

Investigational drug(s) / intervention(s)

AVF creation as indicated by the nephrologist

AVF creation as indicated by the nephrologist: AVF are creation in the OR when asked by the nephrologist team

Study summary

Arteriovenous fistulas (AVFs) are the standard for dialysis sessions. However, this usually requires surgery before dialysis can begin. Given this pre-operative approach, the investigators evaluate the two-year utilization rate of AVFs and seek to understand why they are still not used in some cases.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * First AVF creation Exclusion Criteria: * Minor patient * AVF already

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Benane Dylan Toulouse France

More University Paul Sabatier of Toulouse trials in France

Modified Left Atrial Maze Procedure for Concomitant AF Ablation Enrolling by invitation
Increasing Access to Fertility Preservation for Women with Breast Cancer Recruiting
Evaluating a Health Literacy Intervention to Improve Colorectal Cancer Screening in Underserved Areas Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07548814 on ClinicalTrials.gov ↗ ← All trials in France